Table 59Social network and environment-based therapies versus control evidence summary

Outcome or subgroupNStatistical methodEffect estimate (SMD, 95% CI)
Abstinence
Abstinence post-treatment
PDA post-treatment172SMD (IV, Random, 95% CI)−0.76 (−1.08, −0.43)
Abstinence up to 6-month follow-up
At 6-month follow-up172SMD (IV, Random, 95% CI)−0.75 (−1.08, −0.43)
Abstinence 7- to 12-month follow-up
At 9-month follow-up172SMD (IV, Random, 95% CI)−0.70 (−1.03, −0.38)
At 12-month follow-up172SMD (IV, Random, 95% CI)−0.59 (−0.99, −0.19)
Abstinence >12-month follow-up
At 15-month follow-up172SMD (IV, Random, 95% CI)−0.68 (−1.03, −0.32)
At 18-month follow-up172SMD (IV, Random, 95% CI)−0.28 (−1.02, 0.46)
At 21-month follow-up172SMD (IV, Random, 95% CI)−0.35 (−0.74, 0.05)
At 24-month follow-up172SMD (IV, Random, 95% CI)−0.49 (−0.96, −0.01)
At 27-month follow-up172SMD (IV, Random, 95% CI)−0.31 (−1.12, 0.49)
Amount of alcohol consumed
DDD post-treatment172SMD (IV, Random, 95% CI)−0.07 (−0.41, 0.28)
DDD up to 6-month follow-up
At 6-month follow-up172SMD (IV, Random, 95% CI)−0.54 (−0.86, −0.22)
DDD 7- to 12-month follow-up
At 9 months172SMD (IV, Random, 95% CI)−0.37 (−0.68, −0.05)
At 12-month follow-up172SMD (IV, Random, 95% CI)−0.25 (−0.57, 0.06)
DDD >12-month follow-up
At 15-month follow-up172SMD (IV, Random, 95% CI)−0.35 (−0.83, 0.12)
At 18-month follow-up172SMD (IV, Random, 95% CI)−0.34 (−0.66, −0.03)
At 21-month follow-up172SMD (IV, Random, 95% CI)−0.43 (-0.75, -0.11)
At 24-month follow-up172SMD (IV, Random, 95% CI)−0.11 (−0.43, 0.20)
At 27-month follow-up172SMD (IV, Random, 95% CI)0.06 (−0.26, 0.37)
Attrition (dropout)
Attrition (dropout) post-treatment211RR (M-H, Random, 95% CI)1.36 (0.45, 4.13)
Attrition (dropout) up to 6-month follow-up
At 6 months196RR (M-H, Random, 95% CI)0.54 (0.08, 3.59)
Attrition (dropout) 7- to 12-month follow-up
At 9-month follow-up192RR (M-H, Random, 95% CI)2.41 (0.28, 20.76)
At 12-month follow-up188RR (M-H, Random, 95% CI)Not estimable
Attrition (dropout) >12-month follow-up365RR (M-H, Random, 95% CI)0.78 (0.22, 2.79)
At 18-month follow-up186RR (M-H, Random, 95% CI)0.33 (0.04, 2.64)
At 27-month follow-up179RR (M-H, Random, 95% CI)1.31 (0.26, 6.61)

From: 6, PSYCHOLOGICAL AND PSYCHOSOCIAL INTERVENTIONS

Cover of Alcohol-Use Disorders
Alcohol-Use Disorders: Diagnosis, Assessment and Management of Harmful Drinking and Alcohol Dependence.
NICE Clinical Guidelines, No. 115.
National Collaborating Centre for Mental Health (UK).
Leicester (UK): British Psychological Society; 2011.
Copyright © 2011, The British Psychological Society & The Royal College of Psychiatrists.

All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Enquiries in this regard should be directed to the British Psychological Society.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.